Dread Disease Insurance towards local experience
|
|
- Bryce Hensley
- 6 years ago
- Views:
Transcription
1 Dread Disease Insurance towards local experience Wolfgang Droste IAAHS - Colloquium April 2004 A Berkshire Hathaway Company
2 A Berkshire Hathaway Company?
3 Contents 1. Gen Re s Survey 2. International Comparisons 3. Trends in Cancer Incidence 4. For Your Consideration 3
4 Contents 1. Gen Re s Survey 2. International Comparisons 3. Trends in Cancer Incidence 4. For Your Consideration 4
5 Gen Re s Survey Background information Claims analysis Admitted claims Cancer claims Declinature Incidence rates 5
6 Market Coverage Hong Kong (15), Malaysia (9) and Singapore (7) 4.0 million lives in force on Singapore 33% Hong Kong 22% Malaysia 45% Market Survey and Product Features 6
7 In-force by sex Number of in-force policies issued to women > number of in-force policies issued to men (for age 20 40) 90,000 Number of In-force Policies 80,000 70,000 60,000 50,000 40,000 30,000 20,000 10,000 Male Female Age Market Survey and Product Features 7
8 Average Sum Insured Average claim amount < Average sum insured As at 31/12/2000: $US Claims In-force Difference Hong Kong: 34,922 39, % Malaysia: 9,102 9, % Singapore: 20,672 23, % Market Survey and Product Features 8
9 Sales Volume No. of new policies stable Around 650,000 policies each year New business sum insured increasing US$12.5 billion (1996), US$14.5 billion (2000) Proportion of age 0-19 policies (in-force) increasing 3% (1993), 17% (1998), 15% (2000) Market Survey and Product Features 9
10 Claims Analysis Background information Claims analysis Admitted claims Declinature Cancer claims Incidence rates 10
11 Survey Basis 16,507 claims in total 13,832 Dread Disease claims (of which 87% admitted) 9,518 Admitted claims with cause of claim provided Admitted claims (counted by number of policies): Singapore 45% Hong Kong 23% Malaysia 32% 11
12 Cause of Claim by Territory 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Cause of Claim by Territory Hong Kong Malaysia Singapore Overall Others Total Permanent Disability Other heart surgery excluding Coronary Artery Bypass Surgery Coronary Artery Bypass Surgery Kidney Failure Stroke Heart Attack Cancer Cause of Claim 12
13 Cause of Claim by Duration Breakdown by sex and duration Sex Male Female Duration Number of Claims Cancer 49.5% 53.6% 50.7% 81.8% 83.1% 84.9% Heart Attack 19.5% 19.3% 21.1% 1.6% 1.5% 1.8% Stroke 7.6% 9.3% 9.0% 4.2% 3.4% 4.1% CABS 4.3% 4.7% 4.4% 0.4% 0.4% 0.2% Kidney Failure 2.3% 3.2% 3.6% 3.0% 2.1% 2.2% Other heart surgery excluding CABS 2.8% 2.2% 2.1% 0.7% 0.5% 0.6% TPD 1.8% 1.5% 1.4% 0.4% 0.2% 0.6% Others 12.2% 6.1% 7.7% 8.0% 8.8% 5.5% Cause of Claim 13
14 The Most Common Other Causes of Claim Other Claims Hong Kong Malaysia Singapore Other claims (cause reported) 1st place 2nd place 3rd place Benign brain tumor 14 (8%) Paralysis 12 (7%) Paralysis 20 (9%) Benign brain tumor Coma 13 (5%) 10 (6%) Coma 13 (5%) Benign brain tumor 25 (18%) Encephalitis 10 (7%) 19 (9%) Coma 10 (7%) Blindness Multiple Sclerosis 8 (6%) Cause of Claim 14
15 Cause of Claim by Age Males Claims: % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Others Total Permanent Disability Other heart surgery excluding CABS Coronary Artery Bypass Surgery (CABS) Kidney Failure Stroke Heart Attack Cancer Cause of Claim 15
16 Cause of Claim by Age Females Claims: % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Others Total Permanent Disability Other heart surgery excluding CABS Coronary Artery Bypass Surgery (CABS) Kidney Failure Stroke Heart Attack Cancer Cause of Claim 16
17 Claims Analysis Background information Claims analysis Admitted claims Declinature Cancer claims Incidence rates 17
18 Declinature Rate 25% Declinature rate by calendar year 20% 15% 10% Hong Kong Malaysia Singapore Overall 5% 0% Declinature 18
19 Declinature Rate Declinature Rate by Sex and Territory Male Female 9% 11% 11% 12% 18% 19% Hong Kong Malaysia Singapore 0% 5% 10% 15% 20% Declinature 19
20 Declinature Rate Declinature Rate by Cause of Declinature Suicide Not Covered Definition Not Met Within Waiting Period Non-disclosure Others 0% 5% 10% 15% 20% 25% 30% * Only 11% of declined claims gave the reason for declinature. Declinature 20
21 Declinature Rate Declinature Rate by Cause of Claim Cancer Stroke Heart Attack Coronary Artery Bypass Surgery Kidney Failure Others 0% 5% 10% 15% 20% 25% 30% Declinature 21
22 Claims Analysis Background information Claims analysis Admitted claims Cancer claims Incidence rates 22
23 Selection Effect: Insured Lives Cancer Rates Comparing survey results with population statistics on cancer Notes: Population statistics may include more than one primary cancer site No population data for Malaysia available Source of population statistics: Hong Kong Cancer Registry New cancer cases in year 2000 (all sites excluding skin) Singapore Cancer Registry Report No. 5 - Cancer Incidence in Singapore (all sites excluding skin) Cancer Claims 23
24 Selection Effect Hong Kong Crude Cancer Incidence rates - Male Insured lives ( ) Population (2000) Insured lives/population No. of Claims Cancer incidence Cancer incidence Ratio Duration Duration (all sites but skin) Duration Age 2+ All 2+ All 2+ All % 65% % 79% % 70% % 85% % 80% % 56% % 50% % 38% Cancer Claims 24
25 Selection Effect Hong Kong Crude Cancer Incidence rates - Female Insured lives ( ) Population (2000) Insured lives/population No. of Claims Cancer incidence Cancer incidence Ratio Duration Duration (all sites but skin) Duration Age 2+ All 2+ All 2+ All % 102% % 81% % 92% % 93% % 87% % 68% % 63% % 89% Cancer Claims 25
26 Selection Effect Singapore Crude Cancer Incidence rates - Male No. of Claims Cancer incidence Cancer incidence Ratio Duration Duration (all sites but skin) Duration Age 2+ All 2+ All 2+ All % 44% % 110% % 108% % 89% % 59% % 31% % 60% % 63% Cancer Claims 26
27 Selection Effect Singapore Crude Cancer Incidence rates Female Insured Insured lives ( ) Population (2000) lives/population No. of Claims Cancer incidence Cancer incidence Ratio Duration Duration (all sites but skin) Duration Age 2+ All 2+ All 2+ All % 77% % 127% % 96% % 112% % 98% % 75% % 99% % 98% Cancer Claims 27
28 Site of Cancer (Insured Lives - Male) Hong Kong, Malaysia & Singapore 12% 10% 14% 4% Bone and connective tissue, skin and breast Digestive organs and peritoneum Genitourinary organs Lip, oral cavity and pharynx 27% Lymphatic and haematopoietic tissue Other and unspecified 25% 8% Respiratory and intrathoracic organs Cancer Claims 28
29 Site of Cancer (Hong Kong Insured Lives - Male) Hong Kong 10% 10% 10% 3% Bone and connective tissue, skin and breast Digestive organs and peritoneum Genitourinary organs Lip, oral cavity and pharynx 32% 7% 28% Lymphatic and haematopoietic tissue Other and unspecified Respiratory and intrathoracic organs Cancer Claims 29
30 Site of Cancer (Hong Kong Population - Male) New Cancer Cases in Year 2000 (Age 20-49) 9% 5% 13% 3% Bone and connective tissue, skin and breast Digestive organs and peritoneum Genitourinary organs Lip, oral cavity and pharynx 29% 34% Lymphatic and haematopoietic tissue Other and unspecified 7% Respiratory and intrathoracic organs Cancer Claims 30
31 Site of Cancer (Insured Lives - Female) Hong Kong, Malaysia & Singapore 18% 6% 5% 10% 5% Bone and connective tissue, skin and breast Digestive organs and peritoneum Genitourinary organs Lip, oral cavity and pharynx 11% 45% Lymphatic and haematopoietic tissue Other and unspecified Respiratory and intrathoracic organs Cancer Claims 31
32 Site of Cancer (HK Insured Lives - Female) Hong Kong 10% 5% 9% 4% Bone and connective tissue, skin and breast Digestive organs and peritoneum Genitourinary organs Lip, oral cavity and pharynx 18% 42% Lymphatic and haematopoietic tissue Other and unspecified 12% Respiratory and intrathoracic organs Cancer Claims 32
33 Site of Cancer (Hong Kong Population - Female) New Cancer Cases in Year 2000 (Age 20-49) 9% 6% 9% 6% Bone and connective tissue, skin and breast Digestive organs and peritoneum Genitourinary organs Lip, oral cavity and pharynx 20% 38% Lymphatic and haematopoietic tissue Other and unspecified 12% Respiratory and intrathoracic organs Cancer Claims 33
34 Female Breast Cancer Claims % of Female Cancer Claims due to Breast Cancer Hong Kong Malaysia Singapore Overall 0% 10% 20% 30% 40% 50% Cancer Claims 34
35 Female Breast Cancer Claims Age distribution of female breast cancer claims Age % 10% 20% 30% 40% 50% 60% Hong Kong Malaysia Singapore Overall Cancer Claims 35
36 Female Cancer Claims In-force duration of female claims Breast Cancer Classified* Cancers All Cancers All Dread Diseases 0% 20% 40% 60% 80% 100% duration 0 duration 1 duration 2+ *This refers to cancer claims for which the sites are available Cancer Claims 36
37 Claims Analysis Background information Claims analysis Declinatures Admitted claims Cancer claims Incidence rates 37
38 Acceleration Type Dread Disease Policies Acceleration Type Benefit 20,000 Death cover 5,000 Dread Disease cover Dread Disease Death Payment of 5,000 Death Payment of 20,000 Payment of 15,000 Incidence Rates & Actual/Expected Ratio Analysis 38
39 Incidence Rates: Death with Acceleration DD Males Based on 2,301 actual claims Incidence Rates %? in comparison with last DD survey ( ) Age Crude rates 2003 Graduated rates 2003 Graduated rates 2000 Incidence Rates & Actual/Expected Ratio Analysis 39
40 Incidence Rates: Death with Acceleration DD Females Based on 2,291 actual claims Incidence Rates %? in comparison with last DD survey ( ) Age Crude rates 2003 Graduated rates 2003 Graduated rates 2000 Incidence Rates & Actual/Expected Ratio Analysis 40
41 Incidence Rates: Death with Acceleration DD Death with Dread Disease Acceleration Incidence Rates (log scale) Male Female Age Incidence Rates & Actual/Expected Ratio Analysis 41
42 Incidence Rates: Acceleration DD only Dread Disease only (Acceleration type) Incidence Rates (log scale) Male Female Age Incidence Rates & Actual/Expected Ratio Analysis 42
43 Initial Selection Effect by Territory Acceleration DD, age range 20 60, males All territories Duration 0 No of claims 602 A/E 110% Duration % Duration % *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 43
44 Initial Selection Effect by Territory Acceleration DD, age range 20 60, males All territories Hong Kong No of claims A/E A/E Duration % 93% Duration % 91% Duration % 98% *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 44
45 Initial Selection Effect by Territory Acceleration DD, age range 20 60, males All territories Hong Kong Malaysia No of claims A/E A/E A/E Duration % 93% 135% Duration % 91% 102% Duration % 98% 103% *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 45
46 Initial Selection Effect by Territory Acceleration DD, age range 20 60, males All territories Hong Kong Malaysia Singapore No of claims A/E A/E A/E A/E Duration % 93% 135% 94% Duration % 91% 102% 103% Duration % 98% 103% 99% *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 46
47 Initial Selection Effect by Territory Acceleration DD, age range 20 60, females All territories Duration 0 No of claims 664 A/E 90% Duration % Duration % *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 47
48 Initial Selection Effect by Territory Acceleration DD, age range 20 60, females All territories Hong Kong No of claims A/E A/E Duration % 86% Duration % 85% Duration % 107% *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 48
49 Initial Selection Effect by Territory Acceleration DD, age range 20 60, females All territories Hong Kong Malaysia No of claims A/E A/E A/E Duration % 86% 96% Duration % 85% 71% Duration % 107% 82% *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 49
50 Initial Selection Effect by Territory Acceleration DD, age range 20 60, females All territories Hong Kong Malaysia Singapore No of claims A/E A/E A/E A/E Duration % 86% 96% 88% Duration % 85% 71% 92% Duration % 107% 82% 109% *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 50
51 Initial Selection Effect Additional DD, Male (age 25-60) Female (age 25-55) No of claims A/E No of claims A/E Duration % 73 73% Duration % 91 80% Duration % % *Duration 0 exposure = No of lives * (1 waiting period in days / 365) Initial Selection 51
52 Analysis by Smoking Status No of claims Males A/E No of claims Females A/E Acceleration DD Smoker % % Nonsmoker % % Additional DD Smoker % % Nonsmoker % % Smoking 52
53 Analysis by Smoking Status 250% 200% Smoker/non-smoker differential by age group 150% 100% Male Female 50% 0% Smoking 53
54 Analysis by Calendar Year Males A/E Ratios by Calendar Year 120% 110% 100% 90% 80% 70% Hong Kong Malaysia Singapore Overall Trends 54
55 Analysis by Calendar Year Females A/E Ratios by Calendar Year 140% 130% 120% 110% 100% 90% 80% 70% 60% Hong Kong Malaysia Singapore Overall Trends 55
56 Contents 1. Gen Re s Survey 2. International Comparisons 3. Trends in Cancer Incidence 4. For Your Consideration 56
57 International Comparisons Hong Kong, Malaysia and Singapore (HKMS) Gen Re s Survey ( ) Taiwan Life Insurance Association ( ) UK Report of the Healthcare Study Group ( ) Australia Gen Re Australia Trauma Experience Analysis South Africa Gen Re South Africa Trauma experience Analysis, International Comparison 57
58 Cause of Claim Gen Re s survey Hong Kong, Malaysia and Singapore Sex Male Female Duration Number of Claims Cancer 49.5% 53.6% 50.7% 81.8% 83.1% 84.9% Heart Attack 19.5% 19.3% 21.1% 1.6% 1.5% 1.8% Stroke 7.6% 9.3% 9.0% 4.2% 3.4% 4.1% CABS 4.3% 4.7% 4.4% 0.4% 0.4% 0.2% Kidney Failure 2.3% 3.2% 3.6% 3.0% 2.1% 2.2% Other heart surgery excluding CABS 2.8% 2.2% 2.1% 0.7% 0.5% 0.6% TPD 1.8% 1.5% 1.4% 0.4% 0.2% 0.6% Others 12.2% 6.1% 7.7% 8.0% 8.8% 5.5% Claims Experience 58
59 Cause of Claim - Taiwan Taiwan Sex Male Female Year Number of Claims 921 1,398 2,013 2,539 3,396 1,187 1,637 2,325 2,881 3,731 Cancer 76.8% 78.0% 75.2% 72.9% 73.3% 89.0% 90.2% 88.5% 88.3% 88.1% Heart Attack 7.3% 7.5% 8.6% 9.3% 9.1% 0.6% 0.4% 1.0% 1.1% 0.9% Stroke 4.1% 3.6% 5.0% 4.8% 5.4% 1.9% 1.5% 1.5% 1.6% 1.8% Coronary Artery Bypass 1.4% 1.8% 2.5% 2.4% 2.3% 0.3% 0.5% 0.5% 0.5% 0.4% Kidney Failure 7.3% 7.4% 7.0% 8.1% 7.5% 7.2% 6.4% 7.6% 7.2% 7.8% Major Organ Transplant 1.3% 0.4% 0.3% 1.4% 0.4% 0.5% 0.4% 0.2% 0.6% 0.1% Paralysis 1.8% 1.3% 1.3% 1.2% 2.2% 0.7% 0.7% 0.7% 0.9% 0.9% International Comparisons 59
60 Cause of Claim - UK UK Sex Male Female Duration Cancer 43.2% 49.3% 41.1% 79.7% 79.4% 74.4% Heart Attack 34.6% 25.2% 31.2% 2.1% 2.7% 2.3% Stroke 7.1% 9.8% 8.6% 6.2% 7.0% 6.5% Coronary Artery 6.6% 5.3% 7.1% 1.2% 0.0% 0.8% Bypass Graft Multiple Sclerosis 3.1% 3.3% 3.6% 6.1% 3.8% 8.6% Kidney Failure 1.2% 1.6% 0.8% 1.6% 0.0% 0.5% Major Organ 1.2% 0.0% 0.5% 0.5% 1.0% 0.0% Transplant PTD 3.0% 5.5% 7.1% 2.6% 6.1% 6.9% *** Claims from other causes made up about 2% of male and female DD claims International Comparisons 60
61 Cause of Claim - Australia Australia Sex Male Female Duration Number of Claims Cancer 46.6% 44.4% 43.0% 69.4% 84.1% 82.0% Heart Attack 1.7% 26.4% 27.5% 2.8% 1.6% 3.3% Stroke 6.9% 4.2% 1.9% 11.1% 4.8% 4.7% Coronary Artery Bypass Graft 6.9% 4.2% 7.8% 0.0% 0.0% 0.0% Kidney Failure 0.0% 0.0% 0.3% 0.0% 0.0% 0.0% Other 37.9% 20.8% 19.4% 16.7% 9.5% 10.0% International Comparisons 61
62 Cause of Claim South Africa South Africa Sex Male Female Number of claims Cancer 29% 74% Heart Attack 57% 12% Stroke 7% 12% Other 7% 2% International Comparisons 62
63 Contents 1. Gen Re s Survey 2. International Comparisons 3. Trends in Cancer Incidence 4. For Your Consideration 63
64 Population Trends in Cancer - UK 650 UK: crude rates (age 20+) Rate per 100, Male Female Trends 64
65 Population Trends in Cancer - UK 160 UK: male by site Prostate Lung Colorectal *** Age standardised rates adjusted to 100 in 1989 Trends 65
66 Population Trends in Cancer - UK 120 UK: female by site Lung Breast Cervix Colorectal *** Age standardised rates adjusted to 100 in 1989 Trends 66
67 Population Trends in Cancer Hong Kong 400 Hong Kong: crude rates Rate per 100, Male Female Trends 67
68 Population Trends in Cancer Hong Kong Hong Kong: male by site Trends *** Age standardised rates adjusted to 100 in Prostate Rectum Nasopharynx Lung Stomach 68
69 Population Trends in Cancer Hong Kong 140 Hong Kong: female by site Trends *** Age standardised rates adjusted to 100 in 1989 Breast Nasopharynx Lung Cervix 69
70 Population Trends in Cancer Hong Kong 350 Age standardised incidence rates Rate per 100, Male Female Trends 70
71 Trends in Cancer Hong Kong Insured Lives Rate per 100, Age Adjusted Cancer Incidence Rate (Age20-60) Male Female Trends 71
72 Trends in Heart Attack, Stroke & Heart Surgery 30 Age Adjusted Incidence Rate Hong Kong Male Insured Lives (Age 20-60) Rate per 100, HA, Stroke, CABS, Heart Surgery Trends 72
73 Population mortality by cause of death HK Mortality per Age Malignant neoplasms Heart diseases Injury and poisoning Cerebrovascular disease Pneumonia, all forms All other causes Trends 73
74 Population mortality by cause of death HK Mortality per Age Malignant neoplasms Heart diseases Injury and poisoning Cerebrovascular disease Pneumonia, all forms All other causes Trends 74
75 Population Trends in Cancer - Taiwan Taiwan: crude rates 300 Rate per 100, Male Female Trends 75
76 Population Trends in Cancer - Taiwan Taiwan: age standardised rates 250 Rate per 100, Male Female Trends 76
77 Trends in Cancer Taiwan Insured Lives Taiwan: crude rates 150 Rate per 100, Male Female Trends 77
78 Trends in Cancer Taiwan Insured Lives Taiwan: age standardised rates 150 Rate per 100, Male Female Trends 78
79 Trends in Heart Attack, Stroke & CABS Taiwan insured lives: crude rates 25 Rate per 100, Male Female Trends 79
80 Trends in Heart Attack, Stroke & CABS Taiwan insured lives: age standardised rates 25 Rate per 100, Male Female Trends 80
81 Contents 1. Gen Re s Survey 2. International Comparisons 3. Trends in Cancer Incidence 4. For Your Consideration 81
82 For Your Consideration Shape of rates Definitions 82
83 For Your Consideration Life-threatening Cancer Means the presence of one or more malignant tumours. The malignant tumour is to be characterised by the uncontrollable growth and spread of malignant cells and the invasion and destruction of normal tissue for which major interventionist treatment or surgery (excluding endoscopic procedures alone) is considered medically necessary. The following tumours are excluded: Tumours showing the malignant changes of carcinoma in situ (including cervical dysplasia CIN-1, CIN-2 and CIN-3) or which are histologically described as pre-malignant; All skin cancers including hyperkeratoses, basal cell carcinomas, squamous cell carcinomas and Melanomas of less than 1.5 mm maximum thickness as determined by histological examination using the Breslow method, unless there is evidence of metastasis; Non Life-threatening Cancers such as Prostatic cancers which are histologically described as TNM Classification T1 or are of another equivalent or lesser classification, Papillary Micro-Carcinoma of the Thyroid or Bladder and Chronic Lymphocytic Leukaemia less than Rai Stage 3. 83
84 For Your Consideration Shape of rates Definitions Medical advance & trends 84
85 For Your Consideration Premium Rate Guarantee No. of companies % of in force policies Guaranteed Total Guaranteed Hong Kong: % Malaysia: % Singapore: % Reviewability of definitions None 85
86 For Your Consideration Reviewability Clause Your policy cannot be cancelled by us due to a deterioration in your health or changes in your occupation or pastimes. Your Dread Disease Plan provides financial assistance in the event that you suffer a substantial loss as a result of one of the specified Dread Diseases defined in your Policy Document. Due to the continuing advances in medical treatment and diagnostic techniques, we may need to review the Definitions used in your Policy Document to ensure that in the future they: - remain appropriate with regard to medical terminology and classification, - take into account effective cures and vaccines and modern diagnostic procedures, - include diseases considered appropriate in the future, - exclude diseases which are found to have become minor. We reserve the right, therefore, to adjust your Dread Disease Definitions and/or premium. 86
87 For Your Consideration Shape of rates Definitions Medical advance & trends Effect on mortality studies 87
88 For Your Consideration Death Claims cf. Mortality Tables HKA01 M83/88 Male Female S88/93 0% 10% 20% 30% 40% 50% 88
89 ? Questions? 89
MEDICAL DEFINITIONS REFERENCE GUIDES
MEDICAL DEFINITIONS REFERENCE GUIDES What do the reference guides do? The reference guides provide updated definitions for certain claimable medical conditions under the following policies: St Andrew s
More informationEarly Cancer Care FAQ
If you need more information, you can call 6722 2293 (Mon-Fri, 9am-5pm), email our Financial Protection Specialists at financial2@ocbc.com or visit any of our OCBC branches. Q1. What is this Early Cancer
More informationComprehensive Cancer Cover
Comprehensive Cancer Cover Tech Spec Comprehensive Cancer Cover provides the life insured with cover for the diagnosis and treatment of defined malignant tumours. These tumours must be characterised either
More informationOverview of 2010 Hong Kong Cancer Statistics
Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research
More informationProtection. Cancer Cover. Helping to protect you financially
Protection Cover Helping to protect you financially There are few families in Ireland that have been unaffected by cancer. In fact, by 2020 1 in 2 people in Ireland * will suffer from cancer at some stage
More informationAsteron Lifeguard Changes in Detail
Asteron Lifeguard Changes in Detail Medical Enhancements effective 9 July 2018 Part of the Suncorp Network The purpose of this Changes in Detail document is to inform Asteron Lifeguard customers of Automatic
More informationAsteron Lifeguard Changes in Detail
Asteron Lifeguard Changes in Detail Medical Enhancements effective 9 July 2018 The purpose of this Changes in Detail document is to inform Asteron Lifeguard customers of Automatic Enhancements and introduce
More informationCancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
More informationunexpected costs New Severe Illness offering Sanlam Group Risk Cover Severe Illness insurance Sales Aid
Sales Aid Sanlam Group Risk Cover Severe Illness insurance New Severe Illness offering Sanlam s philosophy for Severe Illness insurance has always been to provide proper cover for the most prevalent diseases.
More informationComprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
More informationFutura. Cancer cover guide
Futura Cancer cover guide Important The contents of this guide and the explanations given are for guidance only and do not affect the Policy Conditions. Cancer cover Cancer cover pays a lump sum if you
More informationOverview of 2009 Hong Kong Cancer Statistics
Overview of 2009 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since 1963 been providing population-based cancer data for epidemiological research and healthcare
More informationComprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
More informationEveryone deserves a better Tomorrow.
Underwritten by Customer Service: 1-888-763-7474 or www.tebcs.com Everyone deserves a better Tomorrow. CriticalAssistance Plus is critical illness insurance that pays benefits for specific illnesses. A
More informationEnhancement Date. Summary. For policyholders. aia.com.au. Sub heading
Main Policy heading Sub heading Date Summary For policyholders aia.com.au 2 Policy Summary Every year AIA Australia upgrades its Priority Protection for Platform Investors benefit range to ensure that
More informationAviva Group Protection Our guide to cancer
ww For employers use only. Aviva Group Protection Our guide to cancer 1 2 In 2013, 131 million working days were lost due to sickness absence in the UK, at an average of 4.4 working days per employee 1.
More informationOur Specified Illness Benefit Is Now Even Better.
Our Specified Illness Benefit Is Now Even Better. Now Covering 47 Specified Illnesses 20 Partial Payment Illnesses Enhancements to our Specified Illness Benefit We have made enhancements to our Specified
More informationOverview of 2013 Hong Kong Cancer Statistics
Overview of 2013 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry (HKCaR) is a population-based cancer registry, collecting the basic demographic data, information
More informationCancer in the Northern Territory :
Cancer in the Northern Territory 1991 21: Incidence, mortality and survival Xiaohua Zhang John Condon Karen Dempsey Lindy Garling Acknowledgements The authors are grateful to the many people, who have
More informationCancer Facts & Figures for African Americans
Cancer Facts & Figures for African Americans What is the Impact of Cancer on African Americans in Indiana? Table 12. Burden of Cancer among African Americans Indiana, 2004 2008 Average number of cases
More informationHazelinks - Cancer incidence analysis (First data extraction)
Hazelinks - Cancer incidence analysis (First data extraction) Authors Prof Malcolm Sim Ms Christina Dimitriadis Dr Caroline Gao Mr Anthony Del Monaco 1 1 Contents Abbreviations... 3 Executive Summary...
More informationMEDICAL DEFINITIONS REFERENCE GUIDE
MEDICAL DEFINITIONS REFERENCE GUIDE Preparation Date: 17 September 2017 This reference guide provides detail of medical definitions that have been reviewed and updated for claimable events occurring on
More informationMEDICAL DEFINITIONS REFERENCE GUIDE
MEDICAL DEFINITIONS REFERENCE GUIDE Preparation Date: 17 September 2017 This reference guide provides detail of medical definitions that have been reviewed and updated for claimable events occurring on
More informationTable E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
More informationCancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer
Cancer in Ontario 1 in 2 Ontarians will develop cancer in their lifetime 1 in 4 Ontarians will die from cancer 14 ONTARIO CANCER STATISTICS 2016 1 Cancer in Ontario An overview Cancer is a group of more
More informationField underwriting pocketbook for life and critical illness insurance
500-5000 Yonge Street Toronto, Ontario M2N 7J8 www.ivari.ca ivari and the ivari logos are trademarks of ivari Canada ULC. ivari is licensed to use such marks. BW-LP1540 9/15 Field underwriting pocketbook
More informationLifecheque Critical Illness Insurance covered conditions
Lifecheque Critical Illness Insurance covered conditions Comparison of contractual language Covered condition Aortic surgery The undergoing of surgery for disease of the aorta requiring excision and surgical
More informationCANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
More information2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
More informationThe Future of Cancer. Lawrence Tsui Global Risk Products Actuary Swiss Reinsurance Company Hong Kong. Session Number: WBR8
Lawrence Tsui Global Risk Products Actuary Swiss Reinsurance Company Hong Kong Session Number: WBR8 Agenda Cancer the basics Cancer past and present Cancer the future CANCER THE BASICS Cancer the basics
More informationOverview of Hong Kong Cancer Statistics of 2015
Overview of Hong Kong Cancer Statistics of 2015 This report summarizes the key cancer statistics of Hong Kong for the year of 2015, which is now available on the website of Hong Kong Cancer Registry. Cancer
More informationCommon Questions about Cancer
6 What is cancer? Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. The cancer cells form tumors that destroy normal tissue. If cancer cells break away from
More informationDefinitions. Peace of mind today and tomorrow. CRITICAL ILLNESS Basic benefit Deluxe benefit. CRITICAL ILLNESS MULTI-PROTECTION (per child)
Definitions Peace of mind today and tomorrow CRITICAL ILLNESS Basic benefit Deluxe benefit CRITICAL ILLNESS MULTI-PROTECTION (per child) Here are the definitions of the critical and non-critical illnesses
More informationSupplementary Online Content
Supplementary Online Content Acuna SA, Fernandes KA, Daly C, et al. Cancer mortality among recipients of solidorgan transplantation in Ontario, Canada. JAMA Oncol. Published online January 7, 2016. doi:10.1001/jamaoncol.2015.5137
More informationCancer in Ireland with estimates for
Cancer in Ireland 1994-2015 with estimates for 2015-2017: Annual Report of the National Cancer Registry 2017 Page ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised
More informationCancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1994-213: Annual Report of the National Cancer Registry 215 Page 3 ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised rate (European standard
More informationCANCER IN IRELAND with estimates for : ANNUAL REPORT OF THE NATIONAL CANCER REGISTRY
CANCER IN IRELAND 1994-2016 with estimates for 2016-2018: ANNUAL REPORT OF THE NATIONAL CANCER REGISTRY 2018 ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised
More informationSuicides increased in 2014
Causes of death 2014 23 May, 2016 Suicides increased in 2014 Diseases of the circulatory system accounted for 30.7% of the deaths recorded in 2014, 2.4% more than in the previous year. The average age
More informationCovered Critical Illness Conditions Appendix Effective Date: March 1, 2010
Covered Critical Illness Conditions Appendix Effective Date: March 1, 2010 This Appendix contains definitions for those Conditions that are covered under the Manulife Financial s Group Critical Illness
More informationS2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
More informationAttending Physician Statement- Cancer or Carcinoma in-situ
Instruction to doctor: This patient is insured with us against the happening of certain contingent events associated with his health. A claim has been submitted in connection with Cancer or Carcinoma in-situ.
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland
More informationAPPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland
More information5.2 Main causes of death Brighton & Hove JSNA 2013
Why is this issue important? We need to know how many people are born and die each year and the main causes of their deaths in order to have well-functioning health s. 1 Key outcomes Mortality rate from
More informationSMOKING AND CANCER RISK
SMOKING AND CANCER RISK The effects of smoking on health were documented in a landmark report by the Surgeon General in 1964. Since then the devastating effect from smoking on millions of American lives
More informationPHA Annual High Claims Report 2018
24 October 2018 Medical device costs, increasing complexity and growing numbers of long hospital stays for mental health problems drive high health insurance claims PHA s Annual High Claims 2018 Report
More informationCancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationCHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster
CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationCovered Critical Illness Conditions Appendix
Covered Critical Illness Conditions Appendix Effective Date: February 1, 2010 This Appendix contains definitions for those Conditions that are covered under the Manulife Financial Group Critical Illness
More informationICD-10-CM - Session 2. Cardiovascular Conditions, Neoplasms and Diabetes
ICD-10-CM - Session 2 Cardiovascular Conditions, Neoplasms and Diabetes Agenda General coding guidelines Acute myocardial infarction Hypertension Cerebrovascular accidents and sequelae Neoplasm and history
More informationNeoplasms/Lymphoma/Leukemia
Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationExtending the Critical Path A presentation by the Critical Illness Definitions and Geographical Variations Working Party
Extending the Critical Path A presentation by the Critical Illness Definitions and Geographical Variations Working Party Agenda Background Hospital Episodes Statistics ti ti data set Methodology for aggregate
More informationANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
More informationCancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1-: Annual Report of the National Cancer Registry ABBREVIATIONS % CI % confidence interval APC Annual percentage change ASR Age-standardised rate (European standard population) CNS Central
More informationCancer and Heart/Stroke
Cancer and Heart/Stroke A plan providing cash benefits to help pay for out-of-pocket costs associated with a cancer, heart attack or stroke diagnosis National General Accident and Health markets products
More informationFacts about Zurich Claims. Zurich Life Risk
acts about Zurich Claims Zurich Life Risk A closer look at the claims Income Protection claims sample extract started Cause Occupation Duration (days) Initial monthly benefit Benefits paid to date 2 4
More informationCancer in Central and South America BOLIVIA
Cancer in Central and South America BOLIVIA This country profile for the Cancer in Central and South America project provides, for each participating cancer registry tables and graphics showing numbers
More informationSMOKING AND CANCER RISK
SMOKING AND CANCER RISK The effects of smoking on health were documented in a landmark report by the Surgeon General in 1964. Since then the devastating effect from smoking on millions of American lives
More informationStatistics at a glance
Sales Aid February 2017 Sanlam Risk Cover Cancer benefits Statistics at a glance The burden of cancer worldwide Cancer is among the leading causes of death* worldwide. In 2012, there were 14 million new
More informationEpidemiology in Texas 2006 Annual Report. Cancer
Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer
More informationMEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site
POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization
More informationDo you need extra cover for very early stage cancer?
Do you need extra cover for very early stage cancer? If it is detected early enough, cancer can be treated successfully thanks to modern interventions. But, even if you have a critical illness policy,
More informationIcd 10 lung cancer with bone mets
Icd 10 lung cancer with bone mets Search While most men today are diagnosed with prostate cancer before they show symptoms, it is important to know the signs if you haven't undergone screening. {{configctrl2.info.metadescription}}
More informationWhat is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*
What is the Impact of Cancer on African Americans in Indiana? Table 13. Burden of Cancer among African Americans Indiana, 2008 2012 Average number of cases per year Rate per 100,000 people* Number of cases
More informationCancer survival in Hong Kong SAR, China,
Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.
More informationTruman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
More informationCOVER WHERE IT MATTERS. Our 17 ABI+ definitions explained. Protection For advisers only
Protection For advisers only COVER WHERE IT MATTERS Our 17 ABI+ definitions explained WE RE ALWAYS LOOKING AT WAYS TO IMPROVE THE COVER WE OFFER. 87%* of critical illness claims paid in 2017 were for cancer,
More informationMedical condition guide. For intermediary use only not for use with your clients
Medical condition guide For intermediary use only not for use with your clients Introduction Listed in this guide are the most common medical disclosures we are asked about. You will find an explanation
More informationBioengineering and World Health. Lecture Twelve
Bioengineering and World Health Lecture Twelve Four Questions What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How
More informationCancer: Past, Present and Future View from the Korean market
Cancer: Past, Present and Future View from the Korean market HyeSun Lim, FIAA Swiss Re Korea, Life & Health Session Number: WBR8 Agenda Market: past and present Risks: on-going concerns Products to come
More informationCANCER FACTS & FIGURES For African Americans
CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5
More informationPHO: Metadata for Mortality from Avoidable Causes
Snapshots @ PHO: Metadata for Mortality from Avoidable Causes This indicator captures individuals under 75 years of age who have died with a condition considered as avoidable recorded as the primary cause
More informationNEZ PERCE COUNTY CANCER PROFILE
NEZ PERCE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a
More informationKOOTENAI COUNTY CANCER PROFILE
KOOTENAI COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a
More informationBOUNDARY COUNTY CANCER PROFILE
BOUNDARY COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a
More informationCancer prevalence. Chapter 7
Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.
More informationHu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).
Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.
More informationADAMS COUNTY CANCER PROFILE
ADAMS COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a group
More informationBONNER COUNTY CANCER PROFILE
BONNER COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a group
More informationBINGHAM COUNTY CANCER PROFILE
BINGHAM COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationCovered Critical Illness Conditions Appendix
Covered Critical Illness Conditions Appendix EFFECTIVE DATE: FEBRUARY 1, 2010 This Appendix contains definitions for those Conditions that are covered under the Manulife Group Critical Illness plan. Covered
More informationSelected tables standardised to Segi population
Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission
More informationFrom A to Z-Codes Matter
From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA While ALL ICD-10-CM codes are important, the Z-codes in ICD-10-CM are frequently considered step-children, supplemental codes
More informationNEZ PERCE COUNTY CANCER PROFILE
NEZ PERCE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a
More informationKOOTENAI COUNTY CANCER PROFILE
KOOTENAI COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a
More informationTWIN FALLS COUNTY CANCER PROFILE
TWIN FALLS COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is
More information*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
More informationNov FromAtoZCodesMatter
Nov 2017 FromAtoZCodesMatter From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA The implementation of ICD-10 brought tens of thousands of new codes. Ranging from A to Z, they portray
More informationJEROME COUNTY CANCER PROFILE
JEROME COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationBUTTE COUNTY CANCER PROFILE
BUTTE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationUNDERWRITING GUIDELINES. Individual Insurance
UNDERWRITING GUIDELINES Individual Insurance TABLE OF CONTENTS About this guide... 4 Medical conditions Asthma...5 Auricular fibrillation...5 Autism...5 Bariatric surgery...5 Barrett s esophagus...5 Cancer
More informationLINCOLN COUNTY CANCER PROFILE
LINCOLN COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationCancer and Heart/Stroke
Cancer and Heart/Stroke A plan providing cash benefits to help pay for out-of-pocket costs associated with a cancer, heart attack or stroke diagnosis National General Accident and Health markets products
More informationSENIOR PDHPE HEALTH PRIORITIES IN AUSTRALIA INTRODUCTORY NOTES NAME SCHOOL / ORGANISATION DATE
SENIOR PDHPE HEALTH PRIORITIES IN AUSTRALIA NAME SCHOOL / ORGANISATION DATE INTRODUCTORY NOTES AUSTRALIA S HEALTH PRIORITIES The current AIHW report, Australia s Health, identifies nine major categories
More informationCANYON COUNTY CANCER PROFILE
CANYON COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More information